WASATCH ADVISORS LP - BRIACELL THERAPEUTICS CORP ownership

BRIACELL THERAPEUTICS CORP's ticker is BCTX and the CUSIP is 10778Y302. A total of 23 filers reported holding BRIACELL THERAPEUTICS CORP in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
WASATCH ADVISORS LP ownership history of BRIACELL THERAPEUTICS CORP
ValueSharesWeighting
Q2 2023$3,929,605
-14.4%
612,088
-0.6%
0.02%
-17.2%
Q1 2023$4,589,781
+158.3%
616,078
+51.5%
0.03%
+141.7%
Q4 2022$1,776,886
-10.6%
406,610
+14.9%
0.01%
-14.3%
Q3 2022$1,988,000
-3.4%
353,744
-0.8%
0.01%
+7.7%
Q2 2022$2,057,000
-17.1%
356,498
+45.7%
0.01%
+8.3%
Q1 2022$2,481,000244,6910.01%
Other shareholders
BRIACELL THERAPEUTICS CORP shareholders Q1 2023
NameSharesValueWeighting ↓
Lynwood Capital Management Inc. 750,000$7,605,0008.16%
K.J. Harrison & Partners Inc 1,351,782$13,749,0002.21%
Redmond Asset Management, LLC 137,942$1,399,0000.42%
SABBY MANAGEMENT, LLC 29,962$304,0000.04%
Concord Wealth Partners 16,775$170,0000.04%
Leonard Green & Partners, L.P. 500,000$5,070,0000.04%
Summit Trail Advisors, LLC 35,000$355,0000.03%
WASATCH ADVISORS LP 244,691$2,481,0000.01%
Apollon Wealth Management, LLC 13,900$141,0000.01%
NATIONAL BANK OF CANADA /FI/ 156,900$1,591,0000.01%
View complete list of BRIACELL THERAPEUTICS CORP shareholders